Skip to search formSkip to main contentSkip to account menu

Praluent

National Institutes of Health

Related topics

Related topics

2 relations
1 ML alirocumab 75 MG/ML Prefilled Syringe [Praluent]

Broader (1)

alirocumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
[PCSK9 inhibition as the new hope for patients with familial hypercholesterolemia, statin intolerance and eventually for those at the highest cardiovascular risk? Focused on alirocumab, Praluent®].
At the present time there are novel hypolipidemics registered globally (alirocumab was the first drug of this group in the world… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)